Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.50 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31689391 | 1.00 | TDP1 (0.75) | TDP1ALDH1A1CYP3A4HSD17B10HPGD | |
| SCHEMBL31689625 | 1.00 | TDP1 (0.75) | TDP1ALDH1A1CYP3A4HSD17B10HPGD | |
| Hydrochloric Acid SCHEMBL4657730 | 0.98 | TDP1 (0.72) | TDP1ALDH1A1CYP3A4HSD17B10HPGD | |
| SCHEMBL6815901 | 0.88 | TDP1 (0.61) | TDP1ALDH1A1CYP3A4HSD17B10TSHR | |
| SCHEMBL297029 | 0.88 | TDP1 (0.61) | TDP1ALDH1A1CYP3A4HSD17B10TSHR | |
| SCHEMBL29475175 | 0.87 | TDP1 (1.00) | TDP1ALDH1A1CYP3A4HSD17B10TSHR | |
| SCHEMBL57166 | 0.87 | TDP1 (1.00) | TDP1ALDH1A1CYP3A4HSD17B10TSHR | |
| SCHEMBL8017939 | 0.85 | ALDH1A1 (0.79) | TDP1ALDH1A1CYP3A4HSD17B10HPGD | |
| SCHEMBL28093598 | 0.84 | TDP1 (0.95) | TDP1ALDH1A1CYP3A4HSD17B10TSHR | |
| SCHEMBL2319993 | 0.83 | TDP1 (0.51) | TDP1ALDH1A1TSHRGAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118004997-A | Preparation method of pore-diameter-adjustable porous carbon material | 东南大学 | 2024-05-10 | — | — | CN | claimed |
| US-20170159189-A1 | METHOD FOR PRODUCING 1,5-DIAMINONAPHTHALENE AND 1-AMINO-5-NITRONAPHTHALENE BY DIRECT ELECTROCHEMICAL AMINATION OF NON-ACTIVATED OR DEACTIVATED AROMATIC SYSTEMS ON BORON-DOPED DIAMOND ANODES | COVESTRO DEUTSCHLAND AG (DE) | 2017-06-08 | — | — | US | claimed |
| EP-3143185-A1 | METHOD FOR PRODUCING 1.5-DIAMINONAPHTHALENE AND 1-AMINO-5-NITRONAPHTHALENE BY DIRECT ELECTROCHEMICAL AMINATION OF NON-ACTIVATED OR DEACTIVATED AROMATIC SYSTEMS ON BORON-DOPED DIAMOND ANODES | Covestro Deutschland AG (DE) | 2017-03-22 | — | — | EP | claimed |
| CN-106414391-A | Method for producing 1.5-diaminonaphthalene and 1-amino-5-nitronaphthalene by direct electrochemical amination of non-activated or deactivated aromatic systems on boron-doped diamond anodes | 科思创德国股份有限公司 | 2017-02-15 | — | — | CN | claimed |
| WO-2015173221-A1 | METHOD FOR PRODUCING 1.5-DIAMINONAPHTHALENE AND 1-AMINO-5-NITRONAPHTHALENE BY DIRECT ELECTROCHEMICAL AMINATION OF NON-ACTIVATED OR DEACTIVATED AROMATIC SYSTEMS ON BORON-DOPED DIAMOND ANODES | COVESTRO DEUTSCHLAND AG (DE) | 2015-11-19 | — | — | WO | claimed |
| US-20110319257-A1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-12-29 | — | — | US | claimed |
| EP-2135313-B1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M INNOVATIVE PROPERTIES CO (US) | 2011-09-14 | — | — | EP | claimed |
| EP-1369412-B1 | Process for the preparation of 5-nitro-3,4-dihydro-1(2H)-naphthalenone, 1,5-naphthalendiamine and 1,5-naphthalendiisocyanate | BAYER MATERIALSCIENCE AG (DE) | 2011-07-27 | — | — | EP | claimed |
| EP-2135313-A1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M Innovative Properties Company (US) | 2009-12-23 | — | — | EP | claimed |
| EP-1295864-B1 | PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES | MITSUI CHEMICALS POLYURETHANES (JP) | 2008-12-03 | — | — | EP | claimed |
| EP-1295864-A1 | PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES | Mitsui Chemicals, Inc. (JP) | 2003-03-26 | — | — | EP | claimed |
| US-20020103401-A1 | Process for the production of 1,5-naphthalenediamine | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-01 | — | — | US | claimed |
| WO-2002051792-A1 | METHOD FOR THE PRODUCTION OF 1,5-NAPHTHALENEDIAMINE | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-04 | — | — | WO | claimed |
| US-6235494-B1 | USING CHELATE COMPOUND | THE SCRIPPS RESEARCH INSTITUTE | 2001-05-22 | — | — | US | claimed |
| US-4598043-A | Method for quantitatively assaying blood coagulation factor XII in human plasma | PENTAPHARM AG (CH) | 1986-07-01 | — | — | US | claimed |
| EP-0078764-B1 | PROCESS FOR THE QUANTITATIVE DETERMINATION OF THE BLOOD CLOTTING FACTOR XII IN HUMAN PLASMA | Pentapharm A.G. (CH) | 1986-01-02 | — | — | EP | claimed |
| US-4480030-A | BLOOD-COAGULATION FACTOR XA | PENTAPHARM A.G. (CH) | 1984-10-30 | — | — | US | claimed |
| US-4440678-A | ARGININES | PENTAPHARM, A.G. (CH) | 1984-04-03 | — | — | US | claimed |
| EP-0034122-B1 | TRIPEPTIDE DERIVATIVES AND THEIR USE IN THE DETERMINATION OF ENZYMES | Pentapharm A.G. (CH) | 1983-09-21 | — | — | EP | claimed |
| EP-0078764-A1 | Process for the quantitative determination of the blood clotting factor XII in human plasma | Pentapharm A.G. (CH) | 1983-05-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103401-A1 | Process for the production of 1,5-naphthalenediamine | BBOX1, CYP4B1, NAT1 | TDP1 1315/4885ALDH1A1 455/4885CYP3A4 4/4885 |
| US-20170159189-A1 | METHOD FOR PRODUCING 1,5-DIAMINONAPHTHALENE AND 1-AMINO-5-NITRONAPHTHALENE BY DIRECT ELECTROCHEMICAL AMINATION OF NON-ACTIVATED OR DEACTIVATED AROMATIC SYSTEMS ON BORON-DOPED DIAMOND ANODES | DAO, APEX1, DDAH1 | TDP1 216/4885ALDH1A1 430/4885CYP3A4 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.